UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

168 SOMATIC WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY MEMBER 3 (WASF3) MUTATIONS IN MYELODYSPLASTIC SYNDROMES AND RELATED MYELOID MALIGNANCIES

Leukemia research, 2015-04, Vol.39, p.S85-S86

2015

Link zum Volltext

Verfügbarkeit prüfen

Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders

Leukemia, 2012-12, Vol.26 (12), p.2447-2454

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms

Leukemia, 2014-01, Vol.28 (1), p.78-87

2014

Link zum Volltext

Verfügbarkeit prüfen

P-010 Distinct methylation signature in MDS patients with SF3B1 mutations confers a novel mechanism of disease pathogenesis

Leukemia research, 2013-05, Vol.37, p.S27-S27

2013

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera

Leukemia, 2012-04, Vol.26 (4), p.563-571

2012

Link zum Volltext

Verfügbarkeit prüfen

SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts

Leukemia, 2012-03, Vol.26 (3), p.542-545

2012

Link zum Volltext

Verfügbarkeit prüfen

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

Leukemia, 2010-10, Vol.24 (10), p.1799-1804

2010

Link zum Volltext

Verfügbarkeit prüfen

Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron

Leukemia, 2015-01, Vol.29 (1), p.188-195

2015

Link zum Volltext

Verfügbarkeit prüfen

P035 Improvement in cytogenetic diagnosis and clinical prognostication using SNP-A karyotyping in combination with metaphase cytogenetics in MDS, MDS/MPD and secondary AML

Leukemia research, 2009-05, Vol.33, p.S78-S79

2009

Link zum Volltext

Verfügbarkeit prüfen

P045 TET2 gene harbors mutations associated with myeloid malignancies

Leukemia research, 2009-05, Vol.33, p.S84-S84

2009

Link zum Volltext

Verfügbarkeit prüfen

Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis

Leukemia, 2014-07, Vol.28 (7), p.1486-1493

2014

Link zum Volltext

Verfügbarkeit prüfen

C021 SNP-array karyotyping complements routine metaphase cytogenetics in the detection of chromosomal aberrations including uniparental disomy in MDS

Leukemia research, 2007, Vol.31, p.S34-S34

2007

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology and risk factors for infections in myelodysplastic syndromes

Transplant infectious disease, 2013-12, Vol.15 (6), p.652-657

2013

Link zum Volltext

Verfügbarkeit prüfen

Base excision repair dysfunction in a subgroup of patients with myelodysplastic syndrome

Leukemia, 2008-03, Vol.22 (3), p.551-558

2008

Link zum Volltext

Verfügbarkeit prüfen

Effect of Chromosomal Lesions Detected by SNP-Array Karyotyping on Survival After Allogeneic HCT for MDS and AML

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S248-S248

2011

Link zum Volltext

Verfügbarkeit prüfen

Differences in Iron Distribution in Patients with Myelodysplastic Syndromes Carrying SF3B1 Mutations Using Energy-dispersive X-ray Spectroscopy (XEDS) and Electron-Energy Loss Spectroscopy (EELS)

Microscopy and microanalysis, 2013-08, Vol.19 (S2), p.234-235

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Leukemia
(8)
Leukemia Research
(5)
Biology Of Blood And Marrow Transplantation
(1)
Microscopy And Microanalysis
(1)
Transplant Infectious Disease
(1)

Menü

Weitere Dienste

Einstellungen

168 SOMATIC WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY MEMBER 3 (WASF3) MUTATIONS IN MYELODYSPLASTIC SYNDROMES AND RELATED MYELOID MALIGNANCIES

Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders

Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms

P-010 Distinct methylation signature in MDS patients with SF3B1 mutations confers a novel mechanism of disease pathogenesis

Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera

SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron

P035 Improvement in cytogenetic diagnosis and clinical prognostication using SNP-A karyotyping in combination with metaphase cytogenetics in MDS, MDS/MPD and secondary AML

P045 TET2 gene harbors mutations associated with myeloid malignancies

Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis

C021 SNP-array karyotyping complements routine metaphase cytogenetics in the detection of chromosomal aberrations including uniparental disomy in MDS

Epidemiology and risk factors for infections in myelodysplastic syndromes

Base excision repair dysfunction in a subgroup of patients with myelodysplastic syndrome

Effect of Chromosomal Lesions Detected by SNP-Array Karyotyping on Survival After Allogeneic HCT for MDS and AML

Differences in Iron Distribution in Patients with Myelodysplastic Syndromes Carrying SF3B1 Mutations Using Energy-dispersive X-ray Spectroscopy (XEDS) and Electron-Energy Loss Spectroscopy (EELS)

Suchergebnisse filtern